Rauthu Subhash R, Shiao Tze Chieh, André Sabine, Miller Michelle C, Madej Élodie, Mayo Kevin H, Gabius Hans-Joachim, Roy René
PharmaQAM, Department of Chemistry, Université du Québec à Montréal, P. O. Box 8888, Succ. Centre-ville, Montréal, QC, H3C 3P8 (Canada).
Chembiochem. 2015 Jan 2;16(1):126-39. doi: 10.1002/cbic.201402474. Epub 2014 Nov 18.
The emerging significance of lectins for pathophysiological processes provides incentive for the design of potent inhibitors. To this end, systematic assessment of contributions to affinity and selectivity by distinct types of synthetic tailoring of glycosides is a salient step, here taken for the aglyconic modifications of two disaccharide core structures. Firstly we report the synthesis of seven N-linked-lactosides and of eight O-linked N-acetyllactosamines, each substituted with a 1,2,3-triazole unit, prepared by copper-catalyzed azide-alkyne cycloaddition (CuAAC). The totally regioselective β-D-(1 → 4) galactosylation of a 6-O-TBDPSi-protected N-acetylglucosamine acceptor provided efficient access to the N-acetyllactosamine precursor. The resulting compounds were then systematically tested for lectin reactivity in two binding assays of increasing biorelevance (inhibition of lectin binding to a surface-presented glycoprotein and to cell surfaces). As well as a plant toxin, we also screened the relative inhibitory potential with adhesion/growth-regulatory galectins (total of eight proteins). This type of modification yielded up to 2.5-fold enhancement for prototype proteins, with further increases for galectins-3 and -4. Moreover, the availability of (15)N-labeled proteins and full assignments enabled (1)H, (15)N HSQC-based measurements for hu- man galectins-1, -3, and -7 against p-nitrophenyl lactopyranoside, a frequently tested standard inhibitor containing an aromatic aglycone. The measurements confirmed the highest affinity against galectin-3 and detected chemical shift differences in its hydrophobic core upon ligand binding, besides common alterations around the canonical contact site for the lactoside residue. What can be accomplished in terms of affinity/selectivity by this type of core extension having been determined, the applied combined strategy should be instrumental for proceeding with defining structure-activity correlations at other bioinspired sites in glycans and beyond the tested lectin types.
凝集素在病理生理过程中日益凸显的重要性为设计强效抑制剂提供了动力。为此,通过对糖苷进行不同类型的合成修饰来系统评估其对亲和力和选择性的贡献是关键一步,本文针对两种二糖核心结构的苷元修饰进行了此项研究。首先,我们报道了通过铜催化的叠氮化物-炔烃环加成反应(CuAAC)制备的七种N-连接乳糖苷和八种O-连接N-乙酰乳糖胺,每种化合物都被一个1,2,3-三唑单元取代。对6-O-TBDPSi保护的N-乙酰葡糖胺受体进行完全区域选择性的β-D-(1→4)半乳糖基化反应,可有效获得N-乙酰乳糖胺前体。然后,在两种生物相关性不断增加的结合试验(抑制凝集素与表面呈现的糖蛋白和细胞表面的结合)中,对所得化合物的凝集素反应性进行了系统测试。除了一种植物毒素外,我们还筛选了粘附/生长调节半乳糖凝集素(共八种蛋白质)的相对抑制潜力。这种修饰类型使原型蛋白的活性增强了2.5倍,半乳糖凝集素-3和-4的活性进一步提高。此外,(15)N标记蛋白的可得性和完全归属使得能够基于(1)H、(15)N HSQC对人类半乳糖凝集素-1、-3和-7与对硝基苯基乳糖吡喃糖苷进行测量,对硝基苯基乳糖吡喃糖苷是一种常用的含有芳香苷元的标准抑制剂。测量结果证实了对半乳糖凝集素-3的最高亲和力,并检测到配体结合后其疏水核心的化学位移差异,以及乳糖苷残基经典接触位点周围的常见变化。确定了这种类型的核心扩展在亲和力/选择性方面所能实现的效果后,所应用的联合策略应有助于在聚糖的其他仿生位点以及除测试的凝集素类型之外定义构效关系。